Last reviewed · How we verify

NCT04609787

Immersive Virtual Reality and Central Sensitization in People With Chronic Pain

Withdrawn NA Last updated 28 November 2023
What this trial tests

NA trial testing Immersive Virtual Reality in Chronic Pain. Withdrawn.

Timeline
5 January 2021
Primary endpoint
1 May 2023
1 May 2023

Quick facts

Lead sponsorTufts University
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Start date5 January 2021
Primary completion1 May 2023
Estimated completion1 May 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Tufts University

Who can join

Adults 25 to 65, any sex, with Chronic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients with chronic low back pain from Dr. Robert Edwards' study at the Brigham \& Women's Pain Institute that examines sensory and pain perceptions in patients with chronic pain who use opioids will complete quantitative sensory testing (QST) and current pain levels will be obtained. Subsequently, 20-minutes of Immersive Virtual Reality (IVR) will be completed and then QST testing will be completed again post-IVR.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Virtual Reality in the Treatment of Adults with Chronic Low Back Pain: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Brea-Gómez B, Torres-Sánchez I, Ortiz-Rubio A, Calvache-Mateo A, et al · · 2021 · cited 57× · PMID 34831562 · DOI 10.3390/ijerph182211806

Verify or expand the search:

Other trials of Immersive Virtual Reality

Trials testing the same drug.

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

Other Tufts University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04609787.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing